- Home
- Medical news & Guidelines
- Anesthesiology
- Cardiology and CTVS
- Critical Care
- Dentistry
- Dermatology
- Diabetes and Endocrinology
- ENT
- Gastroenterology
- Medicine
- Nephrology
- Neurology
- Obstretics-Gynaecology
- Oncology
- Ophthalmology
- Orthopaedics
- Pediatrics-Neonatology
- Psychiatry
- Pulmonology
- Radiology
- Surgery
- Urology
- Laboratory Medicine
- Diet
- Nursing
- Paramedical
- Physiotherapy
- Health news
- Fact Check
- Bone Health Fact Check
- Brain Health Fact Check
- Cancer Related Fact Check
- Child Care Fact Check
- Dental and oral health fact check
- Diabetes and metabolic health fact check
- Diet and Nutrition Fact Check
- Eye and ENT Care Fact Check
- Fitness fact check
- Gut health fact check
- Heart health fact check
- Kidney health fact check
- Medical education fact check
- Men's health fact check
- Respiratory fact check
- Skin and hair care fact check
- Vaccine and Immunization fact check
- Women's health fact check
- AYUSH
- State News
- Andaman and Nicobar Islands
- Andhra Pradesh
- Arunachal Pradesh
- Assam
- Bihar
- Chandigarh
- Chattisgarh
- Dadra and Nagar Haveli
- Daman and Diu
- Delhi
- Goa
- Gujarat
- Haryana
- Himachal Pradesh
- Jammu & Kashmir
- Jharkhand
- Karnataka
- Kerala
- Ladakh
- Lakshadweep
- Madhya Pradesh
- Maharashtra
- Manipur
- Meghalaya
- Mizoram
- Nagaland
- Odisha
- Puducherry
- Punjab
- Rajasthan
- Sikkim
- Tamil Nadu
- Telangana
- Tripura
- Uttar Pradesh
- Uttrakhand
- West Bengal
- Medical Education
- Industry
Lupin launches digital asthma educator platform for guiding patients on use of inhalers
New Delhi: Drug major Lupin on Monday announced the launch of its digital asthma educator platform to guide patients on the correct technique of using inhalers.
The new platform is the latest initiative under Lupin''s long running umbrella programme, Joint Airways Initiative (JAI), for patients suffering from respiratory ailments.
Lupin has launched its digital asthma educator platform. The platform guides asthma patients on the correct technique of using inhalers, the company said in a regulatory filing.
Lupin said, according to estimates, India has nearly 35 million people living with asthma, including children.
While there is no cure for asthma, it is manageable with proper treatment, vigilance, drug adherence and regular medical checks, thus enabling patients to lead a normal life, the company added.
Read also: Lupin launches Arformoterol Tartrate Inhalation Solution in US
Rajeev Sibal, President - India Region Formulations, Lupin said, "Studies indicate that nearly 90 per cent of patients don''t use their inhalers correctly. This can have multiple implications such as developing uncontrolled symptoms, a higher rate of asthma attacks or even flare-ups. We believe this platform would assist healthcare professionals in significantly helping their patients understand correct inhalation technique and better manage their ailment."
Lupin said it will undertake a pan India integrated marketing campaign including social media and radio channels.
Read also: Lupin to introduce healthcare space for doctors, patients with Lupin Digital Health in India
Ruchika Sharma joined Medical Dialogue as an Correspondent for the Business Section in 2019. She covers all the updates in the Pharmaceutical field, Policy, Insurance, Business Healthcare, Medical News, Health News, Pharma News, Healthcare and Investment. She has completed her B.Com from Delhi University and then pursued postgraduation in M.Com. She can be contacted at editorial@medicaldialogues.in Contact no. 011-43720751